The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

7176–7200 of 11823

  • SevereFDA (Drugs)·D-0185-2017·2016-12-21

    Cantrell Drug Company Recalls Phenylephrine HCl Syringes Due to Sterility Concerns

    Cantrell Drug Company is recalling 30,796 syringes of Phenylephrine HCl 1 mg/10 mL due to a lack of assurance of sterility. The recall covers products distributed nationwide.

    Product
    Phenylephrine HCl 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL Single-Dose Syringe, Rx Only Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207, NDC 52533-171-12
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0196-2017·2016-12-21

    Cantrell Drug Recalls Hydromorphone Injection Vials Due to Sterility Concerns

    Cantrell Drug Company is recalling 93 vials of Hydromorphone HCl injection solution nationwide due to a lack of assurance of sterility.

    Product
    Hydromorphone HCl 1 mg/mL in 0.9% Sodium Chloride 30 mL PCA Vial (1 mg/mL), Single-Dose Injection Solution For Slow IV Use, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-006-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0195-2017·2016-12-21

    Cantrell Drug Recalls Hydromorphone Syringes Due to Sterility Concerns

    Cantrell Drug Company is recalling 935 vials of Hydromorphone HCl 50 mg/50 mL single-dose syringes due to a lack of assurance of sterility.

    Product
    HYDROmorphone HCl 50 mg/50 mL in 0.9% Sodium Chloride (1 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-006-04
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0198-2017·2016-12-21

    Cantrell Drug Recalls Midazolam HCl Syringes Due to Sterility Concerns

    Cantrell Drug Company is recalling 37 syringes of Midazolam HCl 50 mg/50 mL due to a lack of assurance of sterility. The product was distributed nationwide.

    Product
    Midazolam HCl 50 mg/50 mL in 0.9% Sodium Chloride (1 mg/mL), Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-001-04
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0191-2017·2016-12-21

    Cantrell Drug Recalls Glycopyrrolate Injection Due to Sterility Concerns

    Cantrell Drug Company is recalling specific lots of Glycopyrrolate injection because the firm cannot assure the sterility of the product.

    Product
    Glycopyrrolate 1 mg/5 mL (0.2 mg/mL) Injection Solution, 5 mL Single-Dose Syringe, For IV Use, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-028-15
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0188-2017·2016-12-21

    Cantrell Drug Recalls Fentanyl Citrate Bags Due to Sterility Concerns

    Cantrell Drug Company is recalling 471 bags of Fentanyl Citrate 1,500 mcg in 0.9% Sodium Chloride due to a lack of assurance of sterility.

    Product
    Fentanyl Citrate 1,500 mcg in 0.9% Sodium Chloride (10 mcg/mL) 150 mL Bag, Single-Dose Bag, Rx Only, Cantrell Drug Company 7321 Cantrell Road Little Road, AR 72207, NDC 52533-024-35
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0201-2017·2016-12-21

    Cantrell Drug Company Recalls Oxytocin Injection Bags Due to Sterility Concerns

    Cantrell Drug Company is recalling 2,681 bags of Oxytocin 30 USP Units due to a lack of assurance of sterility. The affected product is distributed nationwide.

    Product
    Oxytocin 30 USP Units Added to 0.9% Sodium Chloride, 500 mL Bag, Single-Dose Bag, Injection Solution for IV Use Only, Rx Only, Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-056-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0186-2017·2016-12-21

    Cantrell Drug Company Recalls Calcium Chloride Bags Due to Sterility Concerns

    Cantrell Drug Company is recalling 73 bags of Calcium Chloride in 0.9% Sodium Chloride due to a lack of assurance of sterility.

    Product
    Calcium Chloride (20 mg/mL) in 0.9% Sodium Chloride 500 mL Bag, Rx Only, Single-Dose Bag Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-102-09
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0192-2017·2016-12-21

    Cantrell Drug Recalls Heparin Sodium Syringes Due to Sterility Concerns

    Cantrell Drug Company is recalling 1,494 syringes of Heparin Sodium due to a lack of assurance of sterility. The products were distributed nationwide.

    Product
    Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride, Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207, NDC 52533-148-16
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0173-2017·2016-12-14

    Fallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns

    Fallon Wellness Pharmacy is recalling 10 vials of PAPA/PHEN/PROST injection due to environmental monitoring excursions that raise concerns about sterility assurance.

    Product
    PAPA/PHEN/PROST (papverine/phentolamine/prostaglandin) 18 mg/0.6 mg/0.006 mg/mL Injection, 1 mL vials, Fallon Wellness Pharmacy LLC, 1057 Troy-Schenectady Rd, Latham, NY 12110.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0174-2017·2016-12-14

    Fallon Wellness Pharmacy Recalls PAPA/PHEN/PROST Injection Due to Sterility Concerns

    Fallon Wellness Pharmacy is recalling 5 vials of PAPA/PHEN/PROST injection due to environmental monitoring excursions that raise concerns about sterility assurance.

    Product
    PAPA/PHEN/PROST (papverine/phentolamine/prostaglandin) 30 mg/4 mg/0.04 mg/mL Injection, 1 mL vials, Fallon Wellness Pharmacy LLC, 1057 Troy-Schenectady Rd, Latham, NY 12110.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0164-2017·2016-12-07

    Cadila Pharmaceuticals Recalls Microbially Contaminated Ondansetron HCI API

    Cadila Pharmaceuticals is recalling bulk Ondansetron HCI API due to microbial contamination. The affected product was distributed to two US consignees.

    Product
    Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002
    Category
    Drug
    Distribution
    0 states
  • HighFDA (Drugs)·D-0154-2017·2016-12-07

    Par Pharmaceutical Recalls Travoprost Ophthalmic Solution Due to Sterility Concerns

    Par Pharmaceutical is recalling specific lots of Travoprost Ophthalmic Solution because the dropper tips may be damaged, compromising sterility.

    Product
    Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in India, Distributed by: Par Pharmaceutical Cos., Inc, Spring Valley, NY 10977
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0146-2017·2016-11-30

    VistaPharm Recalls Lactulose Solution Due to Bacterial Contamination

    VistaPharm is recalling Lactulose Solution, USP, 10 g/15 mL, because bulk solution tested positive for Burkholderia cepacia bacteria.

    Product
    Lactulose Solution, USP, 10 g/15 mL, 15 mL unit dose cups (NDC 66689-039-01), packaged in 15 mL x 50 unit dose cups per case (NDC 66689-039-50), Rx only, Manufactured by VistaPharm, Inc., Largo, FL 33771.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0153-2017·2016-11-30

    Hospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips

    Hospira is recalling specific lots of Fentanyl Citrate Injection ampules because broken tips may compromise sterility.

    Product
    Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0140-2017·2016-11-23

    Sandoz Recalls L-Cysteine Hydrochloride Injection Due to Sterility Concerns

    Sandoz Inc. is recalling L-Cysteine Hydrochloride Injection because an FDA inspection raised concerns that the product's sterility may be compromised.

    Product
    L-Cysteine Hydrochloride Injection, USP, 0.5 g/10 mL (50 mg/mL), 10 mL Single Dose Vial (NDC 66758-004-01), packaged in 10 x 10mL Vials per carton (NDC 66758-004-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0141-2017·2016-11-23

    Sandoz Recalls L-Cysteine Hydrochloride Injection Due to Sterility Concerns

    Sandoz Inc. is recalling L-Cysteine Hydrochloride Injection vials because an FDA inspection raised concerns that the product's sterility may be compromised.

    Product
    L-Cysteine Hydrochloride Injection, USP, 50 mg/mL, 50 mL Pharmacy Bulk Package Vials (NDC 66758-005-01), packaged in 5 x 50 mL Vials per carton(NDC 66758-005-02), Rx only, Manufactured for: Sandoz, Inc., Princeton, NJ.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0133-2017·2016-11-16

    Sandoz Recalls Transderm Scop Patches Due to Defective Delivery System

    Sandoz Inc is recalling 42,740 cartons of Transderm Scop (scopolamine) transdermal systems in Tennessee due to a defective delivery system that may alter drug release.

    Product
    Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 24 patches Multi pack, Rx only, Marketed by Baxter Healthcare Cop/Novartis, Deerfield, IL 60015, Manufactured by:Alza Corporation, Vacaville, CA 95688 for Novartis Consumer Health Inc., Parsippany, NJ 07054
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0126-2017·2016-11-16

    FDA Recalls Wells Pharmacy Testosterone and Anastrozole Pellets

    Wells Pharmacy Network is recalling compounded Testosterone 200 mg/Anastrozole 9 mg Pellets because they are superpotent or subpotent.

    Product
    Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0125-2017·2016-11-09

    PharMEDium Recalls Succinylcholine Chloride Vials Due to Sterility Concerns

    PharMEDium Services is recalling specific vials of Succinylcholine Chloride because a portion of the batch was compounded outside of validated process media, raising sterility concerns.

    Product
    Succinylcholine Chloride, 20 mg per mL, 200 mg per 10 mL, 10 mL vials, Rx only, PharMEDium Services, LLC, Memphis, TN, NDC 61553-0364-65.
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0113-2017·2016-11-02

    Persantine Tablets Recalled Due to Presence of Foreign 50 mg Tablets

    Boehringer Ingelheim is recalling 2,562 bottles of 75 mg Persantine tablets because 50 mg tablets were found inside the bottles.

    Product
    Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01
    Category
    Drug
    Distribution
    Distributed nationwide